Journal Mobile Options
Table of Contents
Vol. 30, No. 1, 2008
Issue release date: March 2008
Section title: Original Paper
Free Access
Neuroepidemiology 2008;30:45–50
(DOI:10.1159/000115749)

Anti-Inflammatory Agents and Cognitive Decline in a Bi-Racial Population

Grodstein F.a, c, f · Skarupski K.A.a, c · Bienias J.L.a, c · Wilson R.S.b, d, e · Bennett D.A.b, d · Evans D.A.a, c
aRush Institute for Healthy Aging, bRush Alzheimer’s Disease Center, Departments of cInternal Medicine, dNeurological Sciences, and ePsychology, Rush University Medical Center, Chicago, Ill., fChanning Lab, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass., USA
email Corresponding Author

Dr. Francine Grodstein

Channing Lab

181 Longwood Ave

Boston, MA 02115 (USA)

Tel. +1 617 525 2279, Fax +1 617 525 2008, E-Mail fgrodstein@partners.org


References

  1. McGeer PL, Rogers J, McGeer EG: Inflammation, anti-inflammatory agents and Alzheimer disease, the last 12 years. J Alzheimers Dis 2006;9(3 suppl):271–276.
  2. ADAPT Research Group: Naproxen and celecoxib do not prevent AD in early results of a randomized controlled trial. Neurology 2007;68:1800–1808.
  3. Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, Ganguli M: Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry 2001;58:853–858.
  4. Kang JH, Cook NR, Manson J, Buring JE, Grodstein F: Low dose aspirin and cognitive function in the women’s health study cognitive cohort. BMJ 2007;334:987.
  5. De Craen AJ, Gussekloo J, Vrijsen B, Westendorp RG: Meta-analysis of anti-inflammatory drug use and risk of dementia. Am J Epidemiol 2005;161:114–120.
  6. Albert MS, Smith LA, Scherr PA, et al: Use of brief cognitive tests to identify individuals in the community with clinically-diagnosed Alzheimer’s disease. Internatl J Neurosci 1991;57:167–178.
  7. Scherr PA, Albert MS, Funkenstein HH, et al: Correlates of cognitive function in an elderly community population. Am J Epidemiol 1988;128:1084–1010.
  8. Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psych Res 1975;12:189–198.
  9. Smith A: Symbol Digit Modalities Test Manual – Revised. Los Angeles, Western Psychological, 1984.
  10. Diggle PJ, Liang J-Y, Zeger SL: Analysis of Longitudinal Data. Oxford, Oxford University Press, 1994.
  11. Jonker C, Comijs HC, Smits JH: Does aspirin or other NSAIDs reduce the risk of cognitive decline in elderly persons? Results from a population-based study. Neurobiol Aging 2003;24:583–588.
  12. Sturmer T, Glynn RJ, Field TS, Taylor JO, Hennekens CH: Aspirin use and cognitive function in the elderly. Am J Epidemiol 1996;143:683–691.
  13. Kang JH, Grodstein F: Regular use of non-steroidal anti-inflammatory drugs and cognitive function in aging women. Neurology 2003;60:1591–1597.
    External Resources
  14. Akiyama H, Barger S, Barnum S, et al: Inflammation and Alzheimer’s disease. Neurobiol Aging 2000;21:383–421.
  15. Neuroinflammation Working Group: Inflammation and Alzheimer disease. Neurobiol Aging 2000;21:383–421.
  16. Klegeris A, McGeer PL: Non-steroidal anti-inflammatory drugs and other anti-inflammatory agents in the treatment of neurodegenerative disease. Curr Alzheimer Res 2005;2:355–365.
  17. Weggen S, Eriksen JL, Das P, et al: A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 2001;414:212–216.
  18. Steering Committee of the Physicians’ Health Study Research Group: Final report on the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med 1989;321:129–135.
  19. Howard PA, Delafontaine P: Non-steroidal anti-inflammatory drugs and cardiovascular risk. J Am Coll Cardiol 2004;43:519–525.